Aspire-Lakewood Holdings, Inc. (ASBP) vs Ensysce Biosciences, Inc. (ENSC)

Aspire-Lakewood Holdings, Inc. and Ensysce Biosciences, Inc. are both Biotechnology companies. Aspire-Lakewood Holdings, Inc. and Ensysce Biosciences, Inc. are of similar size ($12.1M and $11.6M). Ensysce Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Aspire-Lakewood Holdings, Inc. trades at 0.2×. Ensysce Biosciences, Inc. has the higher net margin (−280.5% vs −11,309.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Aspire-Lakewood Holdings, Inc. leads on 7 and Ensysce Biosciences, Inc. on 6.

Valuation

Metric ASBP ENSC Biotechnology median
P/E 0.24 n/m 8.50
P/S 93.27 1.51 9.71
P/B 0.78 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales (2.70) 1.54 9.21
Earnings yield 413.99% (530.77%) (33.15%)
Free cash flow yield (78.86%) (130.64%) (25.50%)

Profitability

Metric ASBP ENSC Biotechnology median
Gross margin (24.97%) 100.00% 65.16%
Operating margin (7,491.61%) (281.32%) 0.00%
Net margin (11,309.31%) (280.49%) 0.00%
Free cash flow margin (7,355.07%) (196.76%) 0.00%
Return on equity (1,032.15%) (1,295.01%) (56.36%)
Return on assets (152.09%) (295.92%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ASBP ENSC Biotechnology median
Revenue growth (TTM) — (39.29%) 6.02%
EPS growth (last fiscal year) (762.74%) 65.24% 30.26%
Revenue growth, 5-year CAGR — 5.21% 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ASBP ENSC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.99 0.70 4.72
Net debt to EBITDA (0.16) 0.42 0.96

Dividend

Metric ASBP ENSC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ASBP ENSC Biotechnology median
Market cap 12.11m 11.64m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack